Sumitomo Mitsui Trust Group Inc. Sells 32,841 Shares of Kenvue Inc. (NYSE:KVUE)

Sumitomo Mitsui Trust Group Inc. decreased its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 0.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,767,620 shares of the company's stock after selling 32,841 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned approximately 0.25% of Kenvue worth $101,789,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in KVUE. Huntington National Bank lifted its stake in Kenvue by 26.5% in the third quarter. Huntington National Bank now owns 4,161 shares of the company's stock valued at $96,000 after acquiring an additional 871 shares during the last quarter. ING Groep NV lifted its stake in Kenvue by 23.6% in the third quarter. ING Groep NV now owns 3,576,616 shares of the company's stock valued at $82,727,000 after acquiring an additional 681,954 shares during the last quarter. Everence Capital Management Inc. lifted its stake in Kenvue by 122.1% in the fourth quarter. Everence Capital Management Inc. now owns 45,380 shares of the company's stock valued at $969,000 after acquiring an additional 24,950 shares during the last quarter. Saturna Capital Corp lifted its stake in Kenvue by 29.9% in the third quarter. Saturna Capital Corp now owns 1,334,860 shares of the company's stock valued at $30,875,000 after acquiring an additional 307,039 shares during the last quarter. Finally, Golden State Equity Partners lifted its stake in Kenvue by 716.1% in the fourth quarter. Golden State Equity Partners now owns 25,658 shares of the company's stock valued at $548,000 after acquiring an additional 22,514 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on KVUE. Deutsche Bank Aktiengesellschaft cut shares of Kenvue from a "buy" rating to a "hold" rating and cut their price target for the company from $25.00 to $24.00 in a research note on Thursday, December 12th. Bank of America increased their price objective on shares of Kenvue from $24.00 to $27.00 and gave the company a "buy" rating in a research report on Tuesday, October 22nd. Citigroup dropped their price objective on shares of Kenvue from $25.00 to $21.00 and set a "neutral" rating on the stock in a research report on Wednesday, January 15th. Royal Bank of Canada reissued a "sector perform" rating and issued a $24.00 price objective on shares of Kenvue in a research report on Monday, February 3rd. Finally, Barclays dropped their price objective on shares of Kenvue from $23.00 to $21.00 and set an "equal weight" rating on the stock in a research report on Friday, January 17th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $23.00.

Kenvue Price Performance

Kenvue stock traded up $0.05 during trading hours on Wednesday, reaching $20.96. 10,316,961 shares of the stock were exchanged, compared to its average volume of 12,673,827. The company has a market cap of $40.19 billion, a P/E ratio of 39.55, a price-to-earnings-growth ratio of 2.16 and a beta of 1.45. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $24.46. The stock has a 50 day moving average of $21.41 and a two-hundred day moving average of $22.03.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. Equities analysts expect that Kenvue Inc. will post 1.05 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th will be given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a yield of 3.91%. The ex-dividend date is Wednesday, February 12th. Kenvue's dividend payout ratio is 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.